+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Adocia - logo

Adocia is a biotechnology company which focuses on producing treatments for diabetes. It was founded in 2005, and headquartered in Lyon, France. The Company develops a BioChaperone Platform used for therapeutic protein delivery in regenerative medicine and chronic disease areas. There pipeline of products include: Biochaperone Lispro, Biochaperone Combo, Hinsbet, Biochaperone Human Glucagon, Biochaperone Glargine GLP-1, Biochaperone Prandial combinations for T1D.

From
From
From
From
Drug Delivery Systems (DDS) Global Market - Forecast To 2027 - Product Thumbnail Image

Drug Delivery Systems (DDS) Global Market - Forecast To 2027

  • Report
  • July 2021
  • 602 Pages
  • Global
From
Glucagon-like Peptide 1 Global Market Report 2024 - Product Thumbnail Image

Glucagon-like Peptide 1 Global Market Report 2024

  • Report
  • January 2024
  • 200 Pages
  • Global
From
Autoimmune Collaboration and Licensing Deals 2016-2024 - Product Thumbnail Image

Autoimmune Collaboration and Licensing Deals 2016-2024

  • Report
  • April 2024
  • 500 Pages +
  • Global
From
Short Bowel Syndrome - Pipeline Insight, 2024 - Product Thumbnail Image

Short Bowel Syndrome - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 80 Pages
  • Global
From
Alzheimer's Disease - Pipeline Review, H2 2020 - Product Thumbnail Image

Alzheimer's Disease - Pipeline Review, H2 2020

  • Drug Pipelines
  • August 2020
  • 1785 Pages
  • Global
From
Obesity - Pipeline Review, H2 2020 - Product Thumbnail Image

Obesity - Pipeline Review, H2 2020

  • Drug Pipelines
  • November 2020
  • 640 Pages
  • Global
From
Loading Indicator